Reduced MicroRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer

Cancer

Volumn 116, Issue 1, 2010, Pages 41-49

  Gao, Caiping ^a   Zhang, Zhiyu ^a   Liu, Wenzhong ^a   Xiao, Shudong ^a   Gu, Weiqi ^a   Lu, Hong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Epidermal growth factor receptor coamplified and overexpressed protein; Gastric cancer; Helicobacter pylori; microRNA 218; Nuclear factor B

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MICRORNA; MICRORNA 218; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LABELING INDEX; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY EPITHELIUM; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCOSA; UTERINE CERVIX CANCER; WART VIRUS;

ADENOCARCINOMA; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; DOWN-REGULATION; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICRORNAS; NF-KAPPA B; RECEPTOR, EPIDERMAL GROWTH FACTOR; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 74549147303     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24743     Document Type: Article

References (27)

1. [No authors listed] Schistosomes, liver flukes and, Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14, June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241.
2. Calin GA, Croce CM. MicroRNA signatures in human cancers, Nat Rev Cancer. 2006;6:857-866.
3. Bueno MJ, de Castro IP, Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle. 2008;7:3143-318.
4. Schulte JH, Horn S, Schlierf S, et al. MicroRNAs in the pathogenesis of neuroblastoma. Cancer Lett. 2009;274:10-15.
5. Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers [serial online]. Mol Cancer. 2007;6:60.
6. Liu T, Tang H, Lang Y, Liu M, Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett. 2009;273:233-242.
7. Lu Z, Liu M, Stribinskis V, et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene. 2008;27:4373-4379.
8. Zhang Z, Li Z, Gao C, et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest. 2008;88:1358-1366.
9. Arisawa T, Tahara T, Shibata T, et al. A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male subjects. Dig Dis Sci. 2007;52:1691-1697.
10. Petrocca F, Visone R, Onelli MR, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008;13:272-286.
11. Kim do N, Chae HS, Oh ST, et al. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol. 2007;81:1033-1036.
12. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103:2257-2261.
13. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene. 2008;27:2575-2582.
14. Schembri F, Sridhar S, Perdomo C, et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci USA. 2009;106:2319-2324.
15. Wang XY, Smith DI, Frederick L, James CD. Analysis of EGF receptor amplicons reveals amplification of multiple expressed sequences. Oncogene. 1998;16:191-195.
16. Eley GD, Reiter JL, Pandita A, et al. A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma. Neuro-Oncol. 2002;4:86-94.
17. Park S, James CD. ECop (EGFR-coamplified and overexpressed protein), a novel protein, regulates NF-κB transcriptional activity and associated apoptotic response in an IκBa-dependent manner. Oncogene. 2005;24:2495-2502.
18. Ford LP, Cheng A. Using synthetic precursor and inhibitor miRNAs to understand miRNA function. In: Wilusz J, ed. Post-Transcriptional Gene Regulation. Totowa, NJ: Humana Press; 2008:289-301.
19. Lim JW, Kim H, Kim KH. Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab Invest. 2001;81:349-360.
20. Chen C, Ridzon DA, Broomer AJ, et al.Real-time quantification of microRNAs by stem-loop RT-PCR [serial online]. Nucleic Acids Res. 2005;33:e179.
21. Zanette DL, Rivadavia F, Molfetta GA, et al. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res. 2007;40:1435-1440.
22. Hermeking H. p53 enters the microRNA world. Cancer Cell. 2007;12:414-418.
23. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-838.
24. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33:1290-1297.
25. Maeda S, Yoshida H, Ogura K, et al. H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology. 2000;119:97-108.
26. Pikarsky E, Porat RM, Stein I, et al. NF-kB functions as a tumour promoter in inflammation-associated cancer, Nature. 2004;431:461-466.
27. Karin M. Nuclear factor-κB in cancer development and progression. Nature. 2006;441:431-436.